Table 2 Overview of study assessments
Assessments | Screening | Treatment period (daily assessments) | End of study |
|---|---|---|---|
Inclusion/exclusion criteria | X | ||
Consent | X | ||
Demographic data | X | ||
Cancer diagnosis | X | ||
Concurrent medical history | X | ||
Regular medication | X | X | |
Oral intake | X | X | |
Urinary continence | X | X | |
4 hourly Modified Richmond Agitation - Sedation Scale scores | X | ||
4 hourly symptom occurrences | X | ||
As required medication | X | ||
Oral intake | X | ||
Urinary continence | X | ||
Parenteral fluids administered | X | ||
Adverse events | X | ||
Cannulation problems | X | ||
Participant outcome | X |